[1]
Jennifer Sims-Mourtada, “Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy (SBRT)”, CSMM, vol. 4, no. 1, pp. 1–4, Jan. 2018.